Use of antibodies against the cd52 antigen for the treatment...

Details Use of antibodies against the cd52 antigen for the treatment... Use of antibodies against the cd52 antigen for the treatment...

C - Chemistry, Metallurgy

07

K

C07K 16/28 (2006.01) A61K 39/395 (2006.01) A61P 25/00 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2689408

The present invention relates to the use of antibodies against the CD52 antigen, specifically monoclonal antibodies, for the production of medicaments for the treatment of diseases of the central nervous system, in particular transmissible spongiform encephalopathies, diseases that are also called prion diseases.

L'invention concerne l'utilisation d'anticorps dirigés contre l'antigène CD52, spécifiquement des anticorps monoclonaux, pour la production de médicaments destinés à traiter des maladies du système nerveux central, en particulier les encéphalopathies spongiformes transmissibles, également appelées maladies à prions.

Affiliated with

Also associated with

Rating

Use of antibodies against the cd52 antigen for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of antibodies against the cd52 antigen for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of antibodies against the cd52 antigen for the treatment... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1655890